title: Evaluative laboratory testing practices of United States rheumatologists.
abstract: OBJECTIVE
  Several laboratory tests can be used to monitor disease activity in patients with rheumatic diseases. We sought to learn how rheumatologists use evaluative laboratory tests in the care of patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
  
  
  METHODS
  We surveyed United States rheumatologists by mailed questionnaire. Of the 976 rheumatologists who received the questionnaire, 575 responded, for a response rate of 59%.
  
  
  RESULTS
  Eighty-six percent of the respondents reported using either the erythrocyte sedimentation rate (ESR) or C-reactive protein level to monitor patients with RA, 92% used either the anti-DNA antibody level or complement C3 level to monitor patients with SLE, and 95% used either the ESR or ANCA levels to monitor patients with ANCA-associated vasculitis. The frequency of testing was distributed over a broad range, but testing was common. Testing on 50% of the visits or more was reported by 52% of respondents for RA, 59% of respondents for SLE, and 64% of respondents for ANCA-associated vasculitis. Between 7% and 11% of respondents reported testing patients on every visit, regardless of clinical disease activity. The majority of respondents reported not altering the treatment of clinically stable patients based on these test results.
  
  
  CONCLUSIONS
  Evaluative laboratory testing is common, and is rarely used as an independent guide for treatment.
authors.affiliation: Stanford University School of Medicine, California, USA.
authors.forename: F
authors.initials: F
authors.lastname: Donald
authors.forename: M M
authors.initials: MM
authors.lastname: Ward
mesh_terms: D019268:Antibodies, Antineutrophil Cytoplasmic / Q000032:analysis; D000974:Antibodies, Antinuclear / Q000032:analysis; D001172:Arthritis, Rheumatoid / Q000175:diagnosis; D001799:Blood Sedimentation; D019411:Clinical Laboratory Techniques / Q000592:standards; D003176:Complement C3 / Q000032:analysis; D003955:Diagnostic Tests, Routine / Q000592:standards* / Q000706:statistics & numerical data*; D005069:Evaluation Studies as Topic; D006801:Humans; D007753:Laboratories / Q000592:standards / Q000706:statistics & numerical data; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis; D012219:Rheumatology; D011795:Surveys and Questionnaires; D014481:United States; D014657:Vasculitis / Q000175:diagnosis / Q000276:immunology
chemical_list: D019268:Antibodies, Antineutrophil Cytoplasmic; D000974:Antibodies, Antinuclear; D003176:Complement C3